POTOMAC, Md.–(BUSINESS WIRE)– #IGC–IGC Pharma Announces a $3 Million investment: strengthen IGC’s working capital & support the advancement of our IGC-AD1 Phase-2 clinical trial.
Source link
POTOMAC, Md.–(BUSINESS WIRE)– #IGC–IGC Pharma Announces a $3 Million investment: strengthen IGC’s working capital & support the advancement of our IGC-AD1 Phase-2 clinical trial.
Source link